Top View
- Oral Mosapride Can Provide Additional Anti-Emetic
- Prokinetics in the Management of Functional Gastrointestinal Disorders
- Low-Dose Imipramine for Refractory Functional Dyspepsia: a Randomised, Double-Blind, Placebo-Controlled Trial
- A Systematic Review of the Effectiveness of Antianxiety and Antidepressive Agents for Functional Dyspepsia
- 5-HT Receptor Agonists in the Treatment of Gastrointestinal Motility Disorders
- Neuronal 5-HT Receptors and SERT
- 80-86 Research Article Development and Validation of Stability I
- Serotonin Receptors – from Molecular Biology to Clinical Applications
- Serotonin and Its Role in Colonic Function and in Gastrointestinal Disorders Meagan M
- Efficacy of Combination Therapy with Probiotics and Mosapride In
- Print This Article
- Therapeutic Modulators of the Serotonin 5
- Applications of Colorimetric Methods for the Determination of Cinitapride Hydrogen Tartarate in Drug Formulations
- How Serotonin Level Fluctuation Affects the Effectiveness of Treatment in Irritable Bowel Syndrome
- Definition, Pathogenesis, and Management of That Cursed Dyspepsia Pramoda Koduru, Malcolm Irani, and Eamonn M
- Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia: a Randomized, Controlled Trial
- Anti-Emetic Effect of Mosapride Citrate Hydrate, a 5-HT4 Receptor Agonist, on Selective Serotonin Reuptake Inhibitors (Ssris)-Induced Emesis in Experimental Animals
- Pharmacology of Serotonin: What a Clinician Should Know
- Mosapride Citrate Tablet 5 Mg
- Pharmacotherapy for Irritable Bowel Syndrome
- Prokinetic Effect of the 5-HT4R Agonist Mosapride on Canine Gastric Motility
- Selective Antagonist, 5MU)
- Effects of 5-HT4 Selective Receptor Agonist, Mosapride Citrate on Electrocardiogram in Dogs
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation
- Mosapride Citrate, a Novel 5-Ht4 Agonist and Partial 5-Ht3 Antagonist, Ameliorates Constipation in Parkinsonian Patients
- Gastroprokinetic Agent, Mosapride Inhibits 5-HT3 Receptor Currents in NCB-20 Cells Yong Soo Park1 and Ki-Wug Sung2,*
- Efficacy of Ramosetron in Combination with Polyethylene Glycol Of
- 209387Orig1s000
- Analytical Method Development & Validation for Simultaneous
- Synergic Effect of Trimebutine Combined with Mosapride on Gastrointestinal Dysfunction and Visceral Pain Induced in Stress Models
- JNM J Neurogastroenterol Motil, Vol. 27 No. 1 January, 2021
- Acquired Long QT and Brugada Syndromes
- Sample Report US Version Report Number: PGX-AGS00000 Report Date
- Additional Mosapride to Proton Pump Inhibitor for Gastroesophageal Reflux Disease: a Meta-Analysis
- Drug Interaction Between Mosapride and Erythromycin Without Electrocardiographic Changes